NEURORIVE INC

City:

Seoul

Country:

South Korea

Published Applications:

Last publication date:

2023-12-21

Patent Grants:

Last grant date:

2025-05-20

Top Inventors for applications by NEURORIVE INC

These are the the leading inventors for applications assigned to NEURORIVE INC:

Sukchan LEE 4 Yongin-si, South Korea
Yong Ha CHI 4 Seogwipo-si, South Korea
Hyun-Hee RYU 2 Suwon-si, South Korea
Dong Cheol JIANG 1 Wonju-si, South Korea

Miso JEONG 1 Deajeon, South Korea
Miso JEONG 1 Daejeon, South Korea
Hyeonjoo HWANG 1 Seoul, South Korea
Gibeom KWON 1 Suwon-si, South Korea

Dong Cheol JANG 1 Wonju-si, South Korea

Recent patent applications by NEURORIVE INC

NEURORIVE INC based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-12-21

US20230405004A1

Human necessities

COMBINATION THERAPY OF DONEPEZIL AND TADALAFIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR COGNITIVE IMPAIRMENT

#2 | 2023-12-14

US20230398106A1

Human necessities

COMBINATION THERAPY OF DONEPEZIL AND SILDENAFIL FOR THE TREATMENT OF ALZHEIMER'S DISEASE OR COGNITIVE IMPAIRMENT

#3 | 2023-06-01

US20230165866A1

Human necessities

CYCLOSERINE AND PENTOXIFYLLINE COMBINATION THERAPY FOR TREATMENT OF DEPRESSION

#4 | 2022-12-08 ✅ Patent 12,303,530 granted on 2025-05-20

US20220387481A1

Human necessities

Combination therapy of cycloserine and lithium for the treatment of depression

Also check out NEURORIVE INC's (Seoul, South Korea) applicant profile with 1 patent applications submitted.

AssigneeID:

331374 ⎘